Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shot
As per a report published on Benzinga, Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday
Booster shots for Omicron, a variant of COVID-19, be available in the U.S. soon after Labor Day, Politico investigated Monday.
The Food and Drug Administration (FDA) will probably approve the booster shots of Pfizer-BioNTech, Moderna as early as Wednesday as per the reports.
The article also reported that Pfizer/BioNTech’s omicron booster would likely be authorized for people, ages in years 12 and more & Moderna’s booster for adults, with age group 18 years and more.